XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net loss: $ (8,786) $ (11,878) $ (23,183)
Adjustments required to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation 3,046 2,887 3,190
Amortization of intangible assets 1,090 1,996 4,371
Impairment of intangible assets 0 0 3,556
Equity-based compensation 15,575 16,198 14,505
Realized loss (gain), net on sale of available-for-sale marketable securities (14) (90) 55
Amortization of premiums (discounts) on available-for-sale marketable securities (922) (124) 397
Unrealized foreign exchange (gain) loss, net 1,108 (560) (351)
Gain on sale of Intrinsix 0 (11,557) 0
Remeasurement of marketable equity securities 94 2 2,511
Changes in operating assets and liabilities:      
Trade receivables, net (6,777) (25) (3,749)
Prepaid expenses and other assets (4,751) (4,850) (1,126)
Operating lease right-of-use assets 1,167 3,305 (1,456)
Accrued interest on bank deposits 527 (237) 144
Deferred taxes, net (68) 6,684 7,811
Trade payables (261) (818) 511
Deferred revenues 581 (27) (5,493)
Accrued expenses and other payables 477 (182) 333
Accrued payroll and related benefits 2,664 (3,737) 984
Operating lease liability (810) (3,273) 1,504
Income taxes payable (221) 67 2,127
Accrued severance pay, net (248) (112) 283
Net cash provided by (used in) operating activities 3,471 (6,331) 6,924
Cash flows from investing activities:      
Business combination 0 (3,600) 0
Asset acquisition (753) 0 0
Purchase of property and equipment (2,955) (2,884) (3,499)
Proceeds from the sale of Intrinsix, net 540 30,589 0
Investment in bank deposits (2,000) (2,000) (14,000)
Proceeds from bank deposits 10,000 6,000 30,885
Investment in available-for-sale marketable securities (46,864) (40,026) (49,873)
Proceeds from maturity of available-for-sale marketable securities 29,780 10,340 18,196
Proceeds from sale of available-for-sale marketable securities 9,806 12,417 3,175
Net cash provided by (used in) investing activities (2,446) 10,836 (15,116)
Cash flows from financing activities:      
Purchase of treasury stock (8,456) (6,163) (6,785)
Proceeds from exercise of stock-based awards 2,883 3,393 3,479
Net cash used in financing activities (5,573) (2,770) (3,306)
Effect of exchange rate changes on cash and cash equivalents (241) 267 (370)
Increase (decrease) in cash and cash equivalents (4,789) 2,002 (11,868)
Cash and cash equivalents at the beginning of the year 23,287 21,285 33,153
Cash and cash equivalents at the end of the year 18,498 23,287 21,285
Supplemental information of cash-flows activities:      
Income and withholding taxes 6,261 7,398 10,193
Non-cash transactions:      
Transaction costs related to the Intrinsix but unpaid at the end of the year 0 25 0
Property and equipment purchases incurred but unpaid at the end of the year 215 0 25
Right-of-use assets obtained in the exchange for operating lease liabilities 1,324 1,100 5,009
Reconciliation of cash and cash equivalents as shown in the condensed consolidated statements of cash flow:      
Cash and cash equivalents in the Consolidated Balance Sheets 18,498 23,287 20,116
Cash and cash equivalents included in assets of discontinued operation 0 0 1,169
Total cash and cash equivalents in the Consolidated Statements of Cash Flows $ 18,498 $ 23,287 $ 21,285